Skip to content

BB-613 Watch Oximeter

by Bio-Beat Technologies, Ltd.

510(k) K181006

BB-613 Watch Oximeter is a medical device (FDA Class II; FDA product code DQA, Oximeter) made by Bio-Beat Technologies, Ltd., cleared under FDA 510(k) K181006 on 21 Sep 2018, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK181006 Date21 Sep 2018ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 Apr 2018
FDA decision
21 Sep 2018 (Substantially Equivalent)
FDA review time
158 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K181006 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DQA
FDA applicant
Bio-Beat Technologies , Ltd.
Device class
Class II
Regulation
21 CFR Part 870.2700
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code DQA (Oximeter).

Other devices from Bio-Beat Technologies, Ltd.

See all devices from Bio-Beat Technologies, Ltd. →